Showing papers by "Iris F.F. Benzie published in 2003"

Evolution of dietary antioxidants

Abstract: Oxygen is vital for most organisms but, paradoxically, damages key biological sites. Oxygenic threat is met by antioxidants that evolved in parallel with our oxygenic atmosphere. Plants employ antioxidants to defend their structures against reactive oxygen species (ROS; oxidants) produced during photosynthesis. The human body is exposed to these same oxidants, and we have also evolved an effective antioxidant system. However, this is not infallible. ROS breach defences, oxidative damage ensues, accumulates with age, and causes a variety of pathological changes. Plant-based, antioxidant-rich foods traditionally formed the major part of the human diet, and plant-based dietary antioxidants are hypothesized to have an important role in maintaining human health. This hypothesis is logical in evolutionary terms, especially when we consider the relatively hypoxic environment in which humans may have evolved. In this paper, the human diet is discussed briefly in terms of its evolutionary development, different strategies of antioxidant defence are outlined, and evolution of dietary antioxidants is discussed from the perspectives of plant need and our current dietary requirements. Finally, possibilities in regard to dietary antioxidants, evolution, and human health are presented, and an evolutionary cost-benefit analysis is presented in relation to why we lost the ability to make ascorbic acid (vitamin C) although we retained an absolute requirement for it.

Hydrogen peroxide in urine as a potential biomarker of whole body oxidative stress.

Abstract: The level of hydrogen peroxide (H2O2) in urine has been suggested as a potential biomarker of whole body oxidative stress, but issues of stability, reproducibility and biological variation have not been investigated to date. In this study, we used a refined protocol, which demonstrated improved sensitivity and precision, to determine the stability of H2O2 in urine, and to measure its concentration in apparently healthy subjects. We also investigated intra-individual variation within and between days. Results showed that H2O2 in urine is stable for up to 48 h at 4 degrees C, however, storage of urine at room temperature was associated with up to 50% increase in H2O2 concentration over a few hours. Total H2O2 in freshly voided urine from 55 healthy, fasting subjects ranged from 0.84 to 5.71 microM, or 90-1164 micromol H2O2/mol creatinine. Intra-individual variation was wide. Even when concentration corrected and collected at the same time of day, 2- to 3-fold variation was seen over 4 consecutive days, and over the course of a single day the creatinine-corrected H2O2 also varied significantly. We suggest that this large biological variation limits the usefulness of urine H2O2 as a biomarker of oxidative stress, the exception being when the effects of disease, therapy or diet induce very large changes in its concentration.

Antioxidants in tears and plasma: Inter-relationships and effect of vitamin C supplementation

Abstract: Purpose. To investigate inter-relationships between total antioxidant capacity and ascorbate concentration in plasma and tears, and the effect of antioxidant supplementation with reference to these variables. Methods. Twenty-one subjects were studied in this placebo-controlled, cross-over intervention trial. Fasting plasma and tear ascorbate concentrations and total antioxidant capacity (as Ferric Reducing/Antioxidant Power (FRAP)) were measured pre- and post-supplementation with vitamin C (1 g/day). Results. Mean ± SD ascorbate in tears and plasma at entry were 17 ± 6 and 52 ± 13µM, respectively; FRAP values were, respectively, 273 ± 94 and 1101 ± 168µM. There was no significant correlation between tear and plasma levels (r = -0.068; P = 0.771 for ascorbate; r = 0.418; P = 0.059 for FRAP). Neither was significant correlation seen between the two variables in plasma (r = 0.162; P = 0.483) or tears (r = 0.353; P = 0.117). Acute responses (up to 3 hours) showed a similar pattern of increase in both fluids, ...

Assessment of membrane protection by traditional Chinese medicines using a flow cytometric technique: preliminary findings.

Abstract: In this preliminary study, we used a 'living cell' flow-cytometric approach to membrane protection by four traditional Chinese medicines (TCMs). Cells were incubated, separately, for 30 min with aqueous extracts (1.5% w/v) of lingzhi (Ganoderma lucidum), ginger (Zingiber officianale), ginseng (Panax ginseng), and green tea (Camellia sinensis). Membranes were labelled with a fluorescent probe, cells were then incubated with cumene hydroperoxide, and site-specific oxidation induced by iron/ascorbate. Oxidation of membrane lipids quenches fluorescence. Forward-scatter fluorescence was measured at timed intervals after initiation of oxidation. Results indicate that lingzhi and ginger contain antioxidant component(s) that act within the cell membrane and slow lipid peroxidation in situ. Results demonstrate also that this living cell model is a useful biomonitoring tool to help determine molecular aspects of putative health effects of TCMs.

Reflex tear ascorbate in Hong Kong Chinese subjects: method comparison and biological variation.

Abstract: BACKGROUND: Tear ascorbate is important for corneal health. A rapid and simple method for measurement of ascorbate in tears is needed, and adequate knowledge of physiological variation of tear ascorbate is important to facilitate comparative studies of the effect of, for example, contact lens wear and environmental conditions and stresses. However, there are currently no data on physiological variation of tear ascorbate. This study validated a simple and speedy method for tear ascorbate and investigated between-eye and between-day variation in tear ascorbate in healthy young adults. METHODS: Yawn-induced reflex tears were collected from 32 healthy Hong Kong Chinese subjects and measured by both high-performance liquid chromatography (HPLC) and by an enzyme-linked colorimetric method known as FRASC (total ferric reducing (antioxidant) activity and ascorbate concentration measurement). For between-eye variation, yawn reflex tears were collected from each eye of the same 32 healthy subjects, and ascorbate was measured using HPLC; in a separate experiment for between-day variation, tears were collected on two separate days from 14 subjects, and ascorbate was measured by FRASC. RESULTS: Both HPLC and FRASC showed high precision, and results obtained using FRASC were not statistically different from those using HPLC; mean +/- SD were, respectively, 18.5 +/- 4.4 microM and 18.5 +/- 4.8 microM for HPLC and FRASC methods (p = 0.943). No significant between-eye difference in tear ascorbate was found (p = 0.386), and no significant between-day variation was found overall: mean +/- SD ascorbate was 20.0 +/- 6.2 microM on day 1 and 19.3 +/- 6.8 microM on day 2 (p = 0.772). However, between-day variation was large in seven of 14 subjects. CONCLUSION: FRASC is an acceptable alternative to HPLC for measurement of tear ascorbate. Tears for ascorbate investigation can be collected from either eye or, if necessary, from both eyes and pooled. However, tear ascorbate may vary widely from day to day in the same individual. The reasons for this variation require further study but may relate to differences in ascorbate supply or demand within the precorneal tear layer.

Antioxidant Effect of Lercanidipine

Abstract: To the Editor: We were surprised by the effects of lercanidipine reported by Taddei et al1 on the plasma antioxidant capacity, with the ferric reducing (antioxidant) power (FRAP) value increasing from 305.0±31.3 to 435.7±142.9 μmol/L. Typical FRAP values for human plasma usually range from 800 to 1200 μmol/L.2 The apparently low baseline values may be related to the use of ascorbic acid or Trolox™ (rather than a solution of ferrous ions) as calibrator without correcting for their stoichiometric factor, which is 2.0 in the FRAP assay. However, it is more difficult to explain the almost 50% increase in plasma FRAP values after lercanidipine treatment. We have found that lercanidipine itself has no in vitro antioxidant effect in the FRAP assay, but it does undergo extensive first-pass metabolism, and some metabolites could have a direct antioxidant effect. The peak plasma concentration (Cmax) of S-lercanidipine is, at most, around 15 nmol/L,3,4 and although the Cmax for total metabolites was >40 times higher than that of the parent drug,5 this still amounts to <1 μmol/L of total …